Episode Details

Back to Episodes
Med-X Targets Global Pest Control Market as It Prepares for NASDAQ Listing (reserved ticker: MXRX)

Med-X Targets Global Pest Control Market as It Prepares for NASDAQ Listing (reserved ticker: MXRX)

Episode 183 Published 1 month, 4 weeks ago
Description

In this episode of The Watchlist, Ricki Lee speaks with Matthew Mills, Chairman and CEO of Med-X, about the company's Nature-Cide line of naturally derived pest control products and its ambitions to expand across the professional pest control market.

Listeners will hear how Med-X is approaching conventional pesticide use, where Nature-Cide is currently being distributed, and how the company is building relationships across professional pest control, vector control, commercial, residential and agricultural applications.

This discussion covers:

  • Nature-Cide's plant-based approach to pest control
  • Med-X's expanding U.S. distribution network and international ambitions
  • The company's strategic relationship with Mainline Brands, including Mosquito Authority and Pest Authority
  • The potential impact of a NASDAQ listing under the reserved ticker MXRX
  • Med-X's plans for marketing, acquisitions and international expansion

This podcast is made in partnership with Med-X. This podcast is for informational purposes only. Please do your own due diligence. For our full disclaimer, visit: https://stockhouse.com/legal/disclaimer

#MedX #MXRX #PestControl #Biotechnology #Investing #NASDAQ #HealthAndWellness


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us